Karlis Pauksens
Associate professor at Department of Medical Sciences; Infection medicine
- Telephone:
- +46 18 611 56 44
- E-mail:
- Karlis.Pauksens@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset
Infektion, ingång 34, 1 tr - Postal address:
- Akademiska sjukhuset
Infektion, ingång 34, 1 tr
751 85 Uppsala
Publications
Recent publications
-
Part of Infectious Diseases, p. 453-458, 2026
- DOI for Chronic norovirus infection in a patient with Good's syndrome resolved after fecal microbiota transplantion and improved nutrional status
- Download full text (pdf) of Chronic norovirus infection in a patient with Good's syndrome resolved after fecal microbiota transplantion and improved nutrional status
-
A human pan-disease blood atlas of the circulating proteome
Part of Science, 2025
-
Management of cytomegalovirus infections - Swedish recommendations 2023
Part of Infectious Diseases, p. 907-917, 2024
-
Part of Clinical Infectious Diseases, 2023
- DOI for Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
- Download full text (pdf) of Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
-
Part of Upsala Journal of Medical Sciences, 2022
- DOI for A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients
- Download full text (pdf) of A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients
All publications
Articles in journal
-
Part of Infectious Diseases, p. 453-458, 2026
- DOI for Chronic norovirus infection in a patient with Good's syndrome resolved after fecal microbiota transplantion and improved nutrional status
- Download full text (pdf) of Chronic norovirus infection in a patient with Good's syndrome resolved after fecal microbiota transplantion and improved nutrional status
-
A human pan-disease blood atlas of the circulating proteome
Part of Science, 2025
-
Management of cytomegalovirus infections - Swedish recommendations 2023
Part of Infectious Diseases, p. 907-917, 2024
-
Part of Clinical Infectious Diseases, 2023
- DOI for Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
- Download full text (pdf) of Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
-
Part of Upsala Journal of Medical Sciences, 2022
- DOI for A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients
- Download full text (pdf) of A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients
-
Part of Human Vaccines & Immunotherapeutics, 2022
- DOI for Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?
- Download full text (pdf) of Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma: Can the response be predicted?
-
Part of Journal of Infectious Diseases, p. 2025-2034, 2021
- DOI for Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination
- Download full text (pdf) of Immunogenicity of the adjuvanted recombinant zoster vaccine: persistence and anamnestic response to additional doses administered 10 years after primary vaccination
-
Part of Trials, 2021
- DOI for COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial
- Download full text (pdf) of COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial
-
Blood biomarker algorithms for the diagnosis of mycoplasma pneumoniae respiratory infections
Part of JIM - Journal of Immunological Methods, 2021
- DOI for Blood biomarker algorithms for the diagnosis of mycoplasma pneumoniae respiratory infections
- Download full text (pdf) of Blood biomarker algorithms for the diagnosis of mycoplasma pneumoniae respiratory infections
-
Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
Part of Acta Oncologica, p. 771-778, 2021
- DOI for Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
- Download full text (pdf) of Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
-
Part of Therapeutic advances in infectious disease, 2021
- DOI for High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19
- Download full text (pdf) of High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19
-
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Part of BMC Immunology, 2021
- DOI for Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
- Download full text (pdf) of Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
-
Calprotectin, a new biomarker for diagnosis of acute respiratory infections
Part of Scientific Reports, 2020
- DOI for Calprotectin, a new biomarker for diagnosis of acute respiratory infections
- Download full text (pdf) of Calprotectin, a new biomarker for diagnosis of acute respiratory infections
-
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
Part of Breast Cancer Research and Treatment, p. 45-52, 2020
- DOI for Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
- Download full text (pdf) of Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
-
Part of Human Vaccines & Immunotherapeutics, p. 2865-2872, 2019
- DOI for Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials
- Download full text (pdf) of Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials
-
Part of JIM - Journal of Immunological Methods, 2019
-
Part of Vaccine, p. 2482-2493, 2019
- DOI for Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
- Download full text (pdf) of Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
-
Part of Der Internist, 2018
-
Part of Journal of Infectious Diseases, p. 1750-1760, 2018
- DOI for Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
- Download full text (pdf) of Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
-
Part of Leukemia and Lymphoma, p. 1172-1179, 2018
-
Part of Rheumatology, p. 855-856, 2017
-
Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery
Part of Vaccine, p. 909-915, 2017
-
Part of Bone Marrow Transplantation, 2017
-
Part of Clinical and Vaccine Immunology, 2017
-
Part of Vaccine, p. 650-655, 2016
-
Part of Vaccine, p. 863-868, 2016
- DOI for Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults
- Download full text (pdf) of Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults
-
Part of INFECTIOUS DISEASES, p. 443-448, 2016
-
Part of Transplantation, p. 1036-1042, 2015
-
Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults
Part of Journal of Infection, p. 577-584, 2015
-
Part of Clinical and Vaccine Immunology, p. 1025-1032, 2015
- DOI for Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections
- Download full text (pdf) of Human Neutrophil Lipocalin as a Superior Diagnostic Means To Distinguish between Acute Bacterial and Viral Infections
-
Part of JIM - Journal of Immunological Methods, p. 85-90, 2015
-
Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults.
Part of Journal of Infection, p. 577-584, 2015
-
Part of American Journal of Transplantation, p. 2838-2845, 2014
-
Part of Clinical and Vaccine Immunology, p. 651-660, 2014
-
Part of Acta Oncologica, p. 669-679, 2014
-
Part of Acta Oncologica, p. 1212-1220, 2014
-
Part of Vaccine, p. 1745-1753, 2014
-
Part of Infection Ecology & Epidemiology, p. 20766, 2013
-
Part of BMC Infectious Diseases, p. 348, 2013
- DOI for Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial
- Download full text (pdf) of Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial
-
Part of Vaccine, p. 3585-3593, 2013
-
Part of European Journal of Haematology, p. 413-419, 2013
-
Part of Research Journal of Infectious Diseases, 2013
-
Part of Blood, p. 1054, 2012
-
Part of Vaccine, p. 2730-2734, 2010
-
Part of JIM - Journal of Immunological Methods, p. 71-77, 2010
-
Part of Clinical Infectious Diseases, p. 1392-1401, 2009
-
Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity
Part of Virology Journal, p. 52, 2008
-
Part of Scandinavian Journal of Infectious Diseases, p. 326-37, 2008
-
Part of Scandinavian Journal of Infectious Diseases, p. 235-244, 2007
-
Part of Clinical and Vaccine Immunology, p. 44-51, 2007
-
Human cell lines used in a micro neutralization test for measuring influenza-neutralizing antibodies
Part of Scandinavian Journal of Immunology, p. 257-263, 2006
-
Part of Acta bio-medica : Atenei Parmensis, p. 23-25, 2006
-
Part of Scandinavian Journal of Infectious Diseases, p. 882-889, 2005
-
Part of Acta Anaesthesiologica Scandinavica, p. 897-900, 2003
-
Skin infection caused by Mycobacterium szulgai after allogenic bone marrow transplantation
Part of Bone Marrow Transplantation, p. 511-513, 2003
-
Treatment and prevention of influenza: Swedish recommendations
Part of Scandinavian Journal of Infectious Diseases, p. 3-11, 2003
-
Part of Bone Marrow Transplantation, p. 479-484, 2001
-
Part of Clinical Infectious Diseases, p. 342-348, 2000
-
Part of Transplantation, p. 1582-1586, 2000
-
Part of Scandinavian Journal of Infectious Diseases, p. 43-49, 1999
-
Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients
Part of Bone Marrow Transplantation, p. 67-71, 1998
-
Tetanus immunity in patients with hematological malignancies
Part of Supportive Care in Cancer, p. 469-472, 1998
-
Part of Bone Marrow Transplantation, p. 317-323, 1997
-
Antiviral treatment with WIN 54954 reduces mortality in murine Coxsackie virus B3 myocarditis
Part of Circulation, p. 2254-2259, 1996
-
Part of Bone Marrow Transplantation, p. 565-568, 1996
-
Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections
Part of Scandinavian Journal of Infectious Diseases, p. 125-130, 1995
-
Part of Scandinavian Journal of Clinical and Laboratory Investigation, p. 125-131, 1995
-
Part of Clinical and Experimental Allergy, p. 713-719, 1995